Other News

ImpediMed SOZO® Abstract Presentations at Key Scientific Cardiology Meetings Demonstrate Utilization of Bioimpedance Spectroscopy for Heart Failure Patients

BRISBANE, Australia & CARLSBAD, Calif.–(BUSINESS WIRE)–ImpediMed Limited (ASX: IPD), a global provider of medical technology to non-invasively measure, monitor and manage tissue composition and fluid status using bioimpedance spectroscopy (BIS), announces that two abstracts demonstrating utilization of its SOZO® device will be presented during poster presentations by A.J. Accardi, M.D. at the upcoming American […]

4C Medical Technologies Announces $17 Million Series A Financing

MINNEAPOLIS, Sept. 10, 2018 /PRNewswire/ — 4C Medical Technologies, Inc. (4C Medical), a privately-held medical technology company focused on the development of minimally invasive therapies for structural heart disease, today announced that it completed a private placement of shares of its Series A Preferred Stock earlier this week, resulting in total gross proceeds […]

Millipede, Inc. Announces First Implants with New Integrated ICE Delivery System

SANTA ROSA, Calif., Sept. 10, 2018 /PRNewswire/ — Millipede, Inc., a medical device company leading the way in adding to the structural heart toolbox for the interventional cardiologist, has successfully treated two patients utilizing its latest-generation delivery system which incorporates a fully integrated intracardiac echocardiography (ICE) catheter.  The catheter was designed to […]

Medtronic Announces One-Month DAPT Clinical Study in the U.S. and Japan with Resolute Onyx DES in High Bleeding Risk Patients

(GLOBE NEWSWIRE via COMTEX) —The Onyx ONE Clear Study Builds Upon Body of Clinical Evidence to Inform Individualized DAPT Duration Following Stent Procedures DUBLIN – September 10, 2018 – Medtronic plc (NYSE:MDT) today announced the start of the Onyx ONE Clear Study in the U.S. and Japan that will evaluate one-month […]

Medtronic EVP & CFO Karen L. Parkhill to Speak at Morgan Stanley Global Healthcare Conference

(GLOBE NEWSWIRE via COMTEX) –DUBLIN – September 4, 2018 – Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it will participate in the Morgan Stanley 16th Annual Global Healthcare Conference on Friday, September 14, 2018, in New York City. Karen Parkhill, executive vice president and chief financial officer […]

New Report from Vizient Evaluates “MRI-compatible” Cardiac Rhythm Devices

IRVING, Texas–(BUSINESS WIRE)–Vizient, Inc. today released its report “The Beat Goes On: Weighing Clinical Benefits, Patient Selection and Healthcare Economics of MRI-Compatible Cardiac Rhythm Devices”, which discusses the financial impact to hospitals resulting from the sudden and dramatic increase in the use of MRI-compatible CRM devices over the last 18 months. Magnetic resonance imaging (MRI)-compatible […]

Cardiac Insight’s Wearable ECG Sensor, Cardea SOLO™, Continues to Attract Premier Cardiology Groups Across the U.S.; Announces Baltimore Heart Associates and Regional Cardiac Arrhythmia as Customers

KIRKLAND, Wash.–(BUSINESS WIRE)–Cardiac Insight, Inc., a leading U.S. developer of wearable biosensors and diagnostic software systems featuring proprietary automated data analysis algorithms, announced today that its wearable ECG Sensor, Cardea SOLO, continues to attract high-volume cardiology group practices across the U.S. The company unveiled Baltimore Heart Associates of Maryland (www.baltimoreheart.com) […]

InnovHeart Elects Keith D. Dawkins MD as Chairman of the Board

MILAN, Italy, Sept. 6, 2018 /PRNewswire/ — InnovHeart s.r.l., a privately-held, venture-backed developer of transcatheter-delivered mitral valve replacement systems (TMVR) for the treatment of mitral valve disease, announced today that it has appointed veteran medical device executive Keith D. Dawkins, M.D., as Chairman of its Board of Directors. Dr. Dawkins is transitioning from his […]

Leviticus Cardio Announces Successful Completion of Third Chronic Animal Study

PETAH TIKVA, Israel, Sept. 6 2018 /PRNewswire/ — Leviticus Cardio, inventors of the versatile transcutaneous Coplanar Energy Transfer (CET) system for use with implanted left ventricular assist devices (LVADs), announces the successful completion of a 90-day preclinical chronic animal study to evaluate its CET technology in combination with a commercial heart pump. The […]